Search
for
Sort by
Research 91–120 of 464
- Dermatologic Reactions to Targeted Therapy
- Cutaneous Toxicities From Transplantation-Related Medications
- Two Clinically Unusual Cases of Folliculotropic Mycosis Fungoides: One with and the Other without Syringotropism
- Management of Dermatologic Toxicities
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Oral Isotretinoin in HIV-Positive Women with Acne: Report of Three Cases
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Ectopic sebaceous gland: a developmental anomaly
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- Study to compare the efficacy of 50% glycolic acid with 65% trichloroacetic acid in the treatment of atrophic acne scar by CROSS technique
- Successful alopecia universalis treatment with the combination of cyclosporine and oral corticosteroid: a case report
- Acne Syndromes and Mosaicism
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- P164 Cutaneous toxicities occurring during amivantamab treatment: the experience of a single large specialist institution
- Pustular Eruption in a Patient Treated With Trametinib
- Prevalence of Dermatologic Side Effects of Mood Stabilizers in Bipolar Disorder: A Systematic Review and A Meta-Analysis
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study
- Therapeutic potential of oral tofacitinib in alopecia areata: a retrospective study
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- 26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas
- Cetuximab Induced Hidrocystomas: A Case Report
- Follicular Disorders
- Folliculotropic mycosis fungoides complicated by eosinophilia: a case report
- Skin reactions caused by epidermal growth factor receptor inhibitors and their management
- Treatment of acne with intermittent isotretinoin, cohort study
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis